Original Research
Published on 15 Aug 2024
High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
![High socioeconomic impact on prescription behavior despite unrestricted access to disease-modifying therapies in people with multiple sclerosis](https://www.frontiersin.org/files/myhome article library/1458458/1458458_Thumb_400.jpg)
- 207 views
Original Research
Published on 15 Aug 2024
in Multiple Sclerosis and Neuroimmunology
Case Report
Accepted on 13 Aug 2024
in Multiple Sclerosis and Neuroimmunology
Editorial
Published on 13 Aug 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 12 Aug 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 12 Aug 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Accepted on 09 Aug 2024
in Multiple Sclerosis and Neuroimmunology
Review
Published on 09 Aug 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 09 Aug 2024
in Multiple Sclerosis and Neuroimmunology
Brief Research Report
Published on 08 Aug 2024
in Multiple Sclerosis and Neuroimmunology
Hypothesis and Theory
Published on 01 Aug 2024
in Multiple Sclerosis and Neuroimmunology
Review
Published on 29 Jul 2024
in Multiple Sclerosis and Neuroimmunology
Original Research
Published on 24 Jul 2024
in Multiple Sclerosis and Neuroimmunology
Case Report
Published on 23 Jul 2024
in Multiple Sclerosis and Neuroimmunology
Brief Research Report
Published on 23 Jul 2024
in Multiple Sclerosis and Neuroimmunology
Editorial
Published on 17 Jul 2024
in Multiple Sclerosis and Neuroimmunology
Brief Research Report
Published on 17 Jul 2024
in Multiple Sclerosis and Neuroimmunology